Tara E. Seery

Hematology | Oncology

1 Hoag Dr
Newport Beach, CA 92663

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients.

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients.

Journal: Frontiers in oncology

Published: July 29, 2024

Recurrent pancreatic cancer treated with N-803 and PD-L1 t-haNK followed by an EGFR-targeted nanocell drug conjugate.

Recurrent pancreatic cancer treated with N-803 and PD-L1 t-haNK followed by an EGFR-targeted nanocell drug conjugate.

Journal: The oncologist

Published: April 12, 2024

Imaging and clinical correlates with regorafenib in metastatic colorectal cancer.

Imaging and clinical correlates with regorafenib in metastatic colorectal cancer.

Journal: Cancer treatment reviews

Published: January 13, 2020

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 01, 2019

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.

Journal: Cancer discovery

Published: July 27, 2018

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 13, 2017

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial.

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial.

Journal: JAMA oncology

Published: December 16, 2016

Current Options for Third-Line Treatment of Metastatic Colorectal Cancer.

Current Options for Third-Line Treatment of Metastatic Colorectal Cancer.

Journal: Clinical advances in hematology & oncology : H&O

Published: March 24, 2016

Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report.

Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report.

Journal: Cancer management and research

Published: December 08, 2015

Identification and characterization of RET fusions in advanced colorectal cancer.

Identification and characterization of RET fusions in advanced colorectal cancer.

Journal: Oncotarget

Published: April 02, 2015

Composite liver tumors: a radiologic-pathologic correlation.

Composite liver tumors: a radiologic-pathologic correlation.

Journal: Clinical and molecular hepatology

Published: December 31, 2014

Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).

Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).

Journal: Cancer

Published: October 31, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026